Comparison of the application value of contrast-enhanced ultrasound and contrast-enhanced CT in puncture biopsy of peripheral pulmonary lesions [0.03%]
对比剂增强超声与CT在周围型肺小结节穿刺活检中的应用价值比较
Gang Wang,Ji-Cheng Zhang,Zhi-Hua Wang et al.
Gang Wang et al.
Objective: This study assesses the clinical utility of contrast - enhanced ultrasound (CEUS) in comparison to contrast - enhanced computed tomography (CECT) in the context of peripheral lung mass biopsy. The overarching o...
Mitochondrial ribosomal proteins: potential targets for cancer prognosis and therapy [0.03%]
线粒体核糖体蛋白：癌症预后和治疗的潜在靶标
Jianqing Zhu,Na Wen,Wen Chen et al.
Jianqing Zhu et al.
Mitochondrial ribosomal proteins (MRPs) are essential components of mitochondrial ribosomes, responsible for translating proteins encoded by mitochondrial DNA and maintaining mitochondrial energy metabolism and function. Emerging evidence s...
Analysis of three treatment methods for granulomatous lobular mastitis: a retrospective study in a single center [0.03%]
三种肉芽肿性乳腺炎治疗方式的回顾性分析研究
Boyu Shang,Tianyi Zhang,Chang Liu et al.
Boyu Shang et al.
Background: Granulomatous lobular mastitis (GLM) is a rare, benign inflammatory condition of the breast that is difficult to distinguish from breast cancer on the basis of clinical and imaging findings. GLM typically has ...
Pan Ma,Yingjie Xu,Yuhe Yao et al.
Pan Ma et al.
Purpose: This study presents an optimization method for arranging lattice radiotherapy (LRT) targets to enhance the contrast between peak and valley doses, aiming to improve the treatment effectiveness and precision. ...
Copy number gain of MET gene with low level in a metastatic lung adenocarcinoma patient represents response to salvage treatment with savolitinib and osimertinib: a case report [0.03%]
低水平MET基因拷贝数增加的转移性肺腺癌患者使用萨沃利替尼和奥希替尼补救治疗后肿瘤缩小：一例个案报告
Jian Wang,Xinying Dong,Yangxin Liu et al.
Jian Wang et al.
Background: Mesenchymal-epithelial transition (MET) amplification is one of the molecular mechanisms of abnormal MET oncogenic signaling in non-small cell lung cancer (NSCLC), significantly contributing to tumor cell surv...
Association of aggregate index of systemic inflammation with increased all-cause and cardiovascular mortality in female cancer patients [0.03%]
系统性炎症综合指数与女性癌症患者全因和心血管死亡率增加的相关性
Ying Yang,Zelin Hu,Yuqin Ye et al.
Ying Yang et al.
Background: Cancer is a leading cause of death, especially among women, with cancers like breast, ovarian, and cervical cancer presenting unique diagnostic and treatment challenges. Systemic inflammation plays a significa...
HALP score as a prognostic marker for overall survival in advanced pancreatic cancer [0.03%]
HALP评分作为晚期胰腺癌总生存期预后标志物的研究
Nazan Demir,İvo Gökmen,Yasemin Sağdıç Karateke et al.
Nazan Demir et al.
Introduction: Pancreatic cancer is the leading cause of cancer-related deaths worldwide and most of the patients diagnosed at an advanced stage. Clinicians need simple, effective, and repeatable tools to predict the progn...
Comparative efficacy of surgery and radiotherapy in achieving local control in Kimura disease: a retrospective analysis of treatment outcomes [0.03%]
Kimura病局部控制的手术和放疗疗效比较：治疗结果的回顾性分析
Wenlong Lv,Yanbin Chen,Xuezhen Wang et al.
Wenlong Lv et al.
Objective: To evaluate and compare the impact of surgery versus radiotherapy on local control rates in Kimura disease (KD). Methods: A ...
A case report of rare pancreatic lymphoma: wide range of diffuse large B-cell lymphoma located in the body and tail of pancreas [0.03%]
罕见的胰腺淋巴瘤一例：广泛累及胰体尾弥漫大B细胞淋巴瘤
Xiang Song,Weiyu Hu,Li Zhang et al.
Xiang Song et al.
Background: Pancreatic lymphoma is a rare pancreatic malignancy that is challenging to differentiate from diseases such as pancreatic cancer (PC). Although pathological examination of specimens obtained through surgery or...
Jiajia Cao,Yurong Zhang,Ningning Yue et al.
Jiajia Cao et al.
CD58 is a glycoprotein receptor widely distributed on histiocytes that binds to CD2, that takes part in constituting the Immunological Synapses (IS) and activating T/NK cells. Aberrant expression of CD58 has been demonstrated to exert a sig...